The novel treatment of tirzepatide peptide represents a significant development in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide targets two pathways – GLP-1 and GIP – providing improved https://tirzepatidepeptide234798.bloggactif.com/43511814/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment